ReviewFrontiers in medicine2018

Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk.

Nicola Edwards et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.